Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CYCC

Cyclacel Pharmaceuticals, Inc.

Healthcare

Set alert

Price alert · CYCC

All alert types
6.37 0.00 0.00%
As of Sep 11, 2025
6.10 Day range 6.96

52-week range unavailable

Open
6.76
Prev close
6.37
Mkt cap
2.05M
Vol
219.91K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
6.10
High
6.96
Forward P/E
-0.16
Beta
0.56
Short ratio
0.03
Inst. own
18.03%
Dividend
0.00
Ex-div date
50-d avg
0.5528
200-d avg
1.41
1y target
1.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CYCC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-71.04 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -15.1×
FY 2016: -5411×FY 2017: -6695×FY 2018: -3494×FY 2019: -5002×FY 2020: -2208×FY 2021: -436×FY 2022: -84.2×FY 2023: -22.4×FY 2024: -71.8×FY 2025: -15.1×
FY 2016 5y median -71.8× FY 2025
P/S 286×
FY 2016: 77330×FY 2017: 0.0×FY 2018: 175516×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 1217×FY 2024: 18867×FY 2025: 286×
FY 2016 5y median 286× FY 2025
P/B 31.2×
FY 2016: 4567×FY 2017: 2309×FY 2018: 1724×FY 2019: 3364×FY 2020: 563×FY 2021: 221×FY 2022: 88.1×FY 2023: 842×FY 2024: -373×FY 2025: 31.2×
FY 2016 5y median 88.1× FY 2025
P/FCF -44.7×
FY 2016: -6466×FY 2017: -6708×FY 2018: -3906×FY 2019: -4161×FY 2020: -2333×FY 2021: -449×FY 2022: -86.4×FY 2023: -31.7×FY 2024: -102×FY 2025: -44.7×
FY 2016 5y median -86.4× FY 2025
EV/EBITDA 41987×
FY 2016: -4650×FY 2017: -5311×FY 2018: -2764×FY 2019: -4071×FY 2020: -1762×FY 2021: -365×FY 2022: -64.5×FY 2023: -20.0×FY 2024: -67.4×FY 2025: 41987×
FY 2016 5y median -64.5× FY 2025
EV/Sales 281×
FY 2016: 77311×FY 2017: 0.0×FY 2018: 175399×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 1209×FY 2024: 18794×FY 2025: 281×
FY 2016 5y median 281× FY 2025
FCF Yield -2.2%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.0%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.2%FY 2022: -1.2%FY 2023: -3.2%FY 2024: -1.0%FY 2025: -2.2%
FY 2016 5y median -1.2% FY 2025

Profitability

Gross Margin 18.5%
FY 2016: -1024.2%FY 2017: 0.0%FY 2018: -2784.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 18.5%
FY 2016 5y median 18.5% FY 2025
Operating Margin -1128.1%
FY 2016: -1678.5%FY 2017: 0.0%FY 2018: -6365.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -6060.2%FY 2024: -27916.3%FY 2025: -1128.1%
FY 2016 5y median -1128.1% FY 2025
Net Margin -401.3%
FY 2016: -1398.7%FY 2017: 0.0%FY 2018: -4858.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -5370.2%FY 2024: -26074.4%FY 2025: -401.3%
FY 2016 5y median -401.3% FY 2025
ROE -43.8%
FY 2016: -82.6%FY 2017: -34.3%FY 2018: -47.7%FY 2019: -66.9%FY 2020: -25.4%FY 2021: -50.1%FY 2022: -103.7%FY 2023: -3715.8%FY 2024: 515.7%FY 2025: -43.8%
FY 2016 5y median -50.1% FY 2025
ROIC -122.7%
FY 2016: -84.1%FY 2017: -38.3%FY 2018: -52.5%FY 2019: -64.4%FY 2020: -27.0%FY 2021: -51.0%FY 2022: -110.1%FY 2023: -3488.9%FY 2024: 515.9%FY 2025: -122.7%
FY 2016 5y median -110.1% FY 2025
ROA -36.6%
FY 2016: -60.0%FY 2017: -28.7%FY 2018: -36.8%FY 2019: -51.1%FY 2020: -22.9%FY 2021: -43.8%FY 2022: -75.6%FY 2023: -256.2%FY 2024: -273.9%FY 2025: -36.6%
FY 2016 5y median -75.6% FY 2025

Growth (YoY)

Revenue 1637.2%
FY 2016: -56.6%FY 2017: -100.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -89.8%FY 2025: 1637.2%
FY 2016 FY 2025
Operating Income 29.8%
FY 2016: 12.5%FY 2017: 32.9%FY 2018: -0.6%FY 2019: -1.4%FY 2020: -9.9%FY 2021: -115.7%FY 2022: -20.6%FY 2023: 8.0%FY 2024: 52.8%FY 2025: 29.8%
FY 2016 FY 2025
EPS (diluted) -374.3%
FY 2016: 35.2%FY 2017: 73.4%FY 2018: 33.4%FY 2019: 22.6%FY 2020: -32.1%FY 2021: -152.2%FY 2022: 11.2%FY 2023: -0.6%FY 2024: 95.3%FY 2025: -374.3%
FY 2016 FY 2025
Free Cash Flow 40.3%
FY 2016: 30.4%FY 2017: 25.7%FY 2018: 10.0%FY 2019: -40.3%FY 2020: 15.1%FY 2021: -131.2%FY 2022: -12.2%FY 2023: 22.6%FY 2024: 50.4%FY 2025: 40.3%
FY 2016 FY 2025

Financial Health

Current Ratio 4.7×
FY 2016: 3.7×FY 2017: 6.3×FY 2018: 4.4×FY 2019: 5.8×FY 2020: 14.3×FY 2021: 7.6×FY 2022: 3.3×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 4.7×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 3.7×
FY 2016: 3.7×FY 2017: 6.2×FY 2018: 4.3×FY 2019: 5.5×FY 2020: 14.0×FY 2021: 7.5×FY 2022: 3.3×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 3.7×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -701×
FY 2016: 1.2×FY 2017: 2.5×FY 2018: 1.8×FY 2019: 1.1×FY 2020: 3.0×FY 2021: 1.6×FY 2022: 0.7×FY 2023: 0.1×FY 2024: 0.3×FY 2025: -701×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -2.0%
FY 2016: -1.7%FY 2017: -2.7%FY 2018: -2.8%FY 2019: -2.6%FY 2020: -2.4%FY 2021: -1.1%FY 2022: -0.9%FY 2023: -0.9%FY 2024: 0.0%FY 2025: -2.0%
FY 2016 5y median -0.9% FY 2025

Annual · latest fiscal year ends 2025-12-31